Sign Up to like & get
recommendations!
1
Published in 2017 at "European Respiratory Journal"
DOI: 10.1183/1393003.congress-2017.pa940
Abstract: SLS COPD (NCT01551758) was a 12-month, open-label, randomised controlled trial (RCT) that evaluated the effectiveness and safety of initiating fluticasone furoate/vilanterol 100/25µg vs continuing usual care in COPD patients (pts) with exacerbation (Exa) history (Vestbo…
read more here.
Keywords:
sls copd;
study;
demographics clinical;
clinical characteristics ... See more keywords